arrow
V

Vered Daitch

Tel Aviv University
H指数:18
被引数:1,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial

碳青霉烯耐药肠杆菌科细菌(CRE)在黏菌素单药治疗和黏菌素-美罗培南联合治疗后的获得及分子特征:AIDA随机试验结果

2025-11-060
OAAI
A time series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 epidemics: a multicentre cross-national ecological study on behalf of QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics study project

一种时间序列分析方法,用于量化COVID-19疫情期间抗生素耐药性和抗生素消耗量的变化:一项代表“QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics”研究项目的多中心跨国生态学研究

2025-06-160
OAAI
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis
2023-07-032
OAAI
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii

耐碳青霉烯类鲍曼不动杆菌中粘菌素异源耐药的患病率和临床后果以及完全耐药的演变

2023-06-1517
OAAI
Risk Factors and Multidimensional Assessment of Long Coronavirus Disease Fatigue: A Nested Case-Control Study
2022-04-1142
OA
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
2020-09-0158
OAAI
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

在耐碳青霉烯类细菌引起的感染患者中,多粘菌素-美罗培南联合治疗与多粘菌素单药治疗后的多粘菌素耐药性发展

2019-11-2311
PREAI
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

多粘菌素单用与多粘菌素联合美罗培南治疗耐碳青霉烯类革兰氏阴性菌引起的严重感染: 一项开放标签、随机对照试验

2018-04-01441
PREAI